Stable knock-down of efflux transporters leads to reduced glucuronidation in UGT1A1-overexpressing HeLa cells: the evidence for glucuronidation-transport interplay.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Pharmaceutics

• Publication date

  2015-03-11

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/mp5008019PMID 25741749
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of Chrysin Glucuronidation in UGT1A1-Overexpressing HeLa Cells: Elucidating the Transporters Responsible for Efflux of Glucuronide

  2015cited by this paper
• An evaluation of the latest in vitro tools for drug metabolism studies

  2014cited by this paper
• Comparative analysis of glucuronidation of ethanol in treeshrews, rats and humans

  2014cited by this paper
• Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences

  2014cited by this paper
• Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes

  2014cited by this paper
• Identification of glucuronidation and biliary excretion as the main mechanisms for gossypol clearance: in vivo and in vitro evidence

  2014cited by this paper
• Drug transporters in drug efficacy and toxicity.

  2012cited by this paper
• Pharmacokinetic interplay of phase II metabolism and transport: a theoretical study.

  2012cited by this paper
• A New Strategy to Rapidly Evaluate Kinetics of Glucuronide Efflux by Breast Cancer Resistance Protein (BCRP/ABCG2)

  2012cited by this paper
• Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.

  2012cited by this paper
• UDP-Glucuronosyltransferase (UGT) 1A9-Overexpressing HeLa Cells Is an Appropriate Tool to Delineate the Kinetic Interplay between Breast Cancer Resistance Protein (BRCP) and UGT and to Rapidly Identify the Glucuronide Substrates of BCRP

  2012cited by this paper
• Breast Cancer Resistance Protein (ABCG2) Determines Distribution of Genistein Phase II Metabolites: Reevaluation of the Roles of ABCG2 in the Disposition of Genistein

  2012cited by this paper
• Substrate inhibition kinetics in drug metabolism reactions

  2011cited by this paper
• Regioselective Glucuronidation of Flavonols by Six Human UGT1A Isoforms

  2011cited by this paper
• Caco-2 cell monolayers as a tool to study simultaneous phase II metabolism and metabolite efflux of indomethacin, paracetamol and 1-naphthol.

  2010cited by this paper
• Pharmacogenetics of irinotecan disposition and toxicity: a review.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Purification of RNA using TRIzol (TRI reagent).

  2010cited by this paper
• Phase II drug metabolizing enzymes.

  2010cited by this paper
• Species and Gender Differences Affect the Metabolism of Emodin via Glucuronidation

  2010cited by this paper
• Transport-metabolism interplay.

  2009cited by this paper
• Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs

  2009cited by this paper
• The drug transporter-metabolism alliance: uncovering and defining the interplay.

  2009cited by this paper
• Endogenous Gene and Protein Expression of Drug-Transporting Proteins in Cell Lines Routinely Used in Drug Discovery Programs

  2009cited by this paper
• Disposition of naringenin via glucuronidation pathway is affected by compensating efflux transporters of hydrophilic glucuronides.

  2009cited by this paper
• Structure and concentration changes affect characterization of UGT isoform-specific metabolism of isoflavones.

  2009cited by this paper
• Interplay of transporters and enzymes in drug and metabolite processing.

  2009cited by this paper
• Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.

  2009cited by this paper
• Interplay of drug metabolism and transport: a real phenomenon or an artifact of the site of measurement?

  2009cited by this paper
• Natural polyphenol disposition via coupled metabolic pathways

  2007cited by this paper
• Quantitation assay for absorption and first-pass metabolism of emodin in isolated rat small intestine using liquid chromatography-tandem mass spectrometry.

  2007cited by this paper
• BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT

  2006cited by this paper
• Pharmacogenetics of Uridine Diphosphoglucuronosyltransferase (UGT) 1A Family Members and its Role in Patient Response to Irinotecan

  2006cited by this paper
• IN VITRO AND IN VIVO CORRELATION OF HEPATIC TRANSPORTER EFFECTS ON ERYTHROMYCIN METABOLISM: CHARACTERIZING THE IMPORTANCE OF TRANSPORTER-ENZYME INTERPLAY

  2006cited by this paper
• Predicting in vivo drug interactions from in vitro drug discovery data

  2005cited by this paper
• Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.

  2005cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Ex Situ Inhibition of Hepatic Uptake and Efflux Significantly Changes Metabolism: Hepatic Enzyme-Transporter Interplay

  2004cited by this paper
• In Vivo Modulation of Intestinal CYP3A Metabolism by P-Glycoprotein: Studies Using the Rat Single-Pass Intestinal Perfusion Model

  2003cited by this paper
• Atypical kinetic profiles in drug metabolism reactions.

  2002cited by this paper
• Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.

  2002cited by this paper
• Human UDP-glucuronosyltransferases: metabolism, expression, and disease.

  2000cited by this paper
• Absorption and metabolism of genistein in isolated rat small intestine.

  2000cited by this paper
• Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985).

  1988cited by this paper

• Pharmacokinetics of oxfendazole and oxyclozanide following single and combined oral administration in goats

  2023cites this paper
• Pharmacokinetics and pharmacokinetic interactions of orally administered oxfendazole and oxyclozanide tablet formulation to sheep.

  2022cites this paper
• Discovery and Characterization of the Key Constituents in Ginkgo biloba Leaf Extract With Potent Inhibitory Effects on Human UDP-Glucuronosyltransferase 1A1

  2022cites this paper
• Methylophiopogonanone A is a naturally occurring broad‐spectrum inhibitor against human UDP‐glucuronosyltransferases: Inhibition behaviours and implication in herb‐drug interactions

  2021cites this paper
• Characterization of Formononetin Sulfonation in SULT1A3 Overexpressing HKE293 Cells: Involvement of Multidrug Resistance-Associated Protein 4 in Excretion of Sulfate

  2021cites this paper
• An ultra-sensitive and easy-to-use assay for sensing human UGT1A1 activities in biological systems

  2020cites this paper
• Metabolism and disposition of corylifol A from Psoralea corylifolia: metabolite mapping, isozyme contribution, species differences and identification of efflux transporters for corylifol A-O-glucuronide in HeLa1A1 cells

  2020influential citation
• An update on polyphenol disposition via coupled metabolic pathways

  2019cites this paper
• Plant phenolics as functional food ingredients.

  2019cites this paper
• Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin

  2019cites this paper
• Mechanism of the efflux transport of demethoxycurcumin-O-glucuronides in HeLa cells stably transfected with UDP-glucuronosyltransferase 1A1

  2019cites this paper
• Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it

  2019cites this paper
• The Mechanisms behind the Biological Activity of Flavonoids.

  2019cites this paper
• Disposition of mianserin and cyclizine in UGT2B10-overexpressing HEK293 cells: Identification of UGT2B10 as a novel N-glucosidation enzyme and BCRP as an N-glucoside transporter

  2018cites this paper
• Chemical inhibition and stable knock-down of efflux transporters leads to reduced glucuronidation of wushanicaritin in UGT1A1-overexpressing HeLa cells: the role of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins (MRPs) in the excretion of glucuronides.

  2018cites this paper
• REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1

  2018cites this paper
• Flaxseed Lignan Metabolites Modulate Hepatocellular Cholesterol Trafficking In HepaRG

  2018cites this paper
• Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance‐associated protein 4 (MRP4) in sulfate efflux of liquiritigenin

  2018cites this paper
• The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells.

  2018influential citation
• Efflux excretion of bisdemethoxycurcumin‐O‐glucuronide in UGT1A1‐overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance‐associated proteins 1 (MRP1) as the glucuronide transporters

  2018cites this paper
• Interplay of Efflux Transporters with Glucuronidation and Its Impact on Subcellular Aglycone and Glucuronide Disposition: A Case Study with Kaempferol.

  2018cites this paper
• Disposition of Mianserin and Cyclizine in UGT2B10-Overexpressing Human Embryonic Kidney 293 Cells: Identification of UGT2B10 as a Novel N-Glucosidation Enzyme and Breast Cancer Resistance Protein as an N-Glucoside Transporter

  2018cites this paper
• Regulates CYP 7 A 1 through Repression of Liver Receptor Homolog-1

  2017cites this paper
• Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides

  2017cites this paper
• Profiles and Gender-Specifics of UDP-Glucuronosyltransferases and Sulfotransferases Expressions in the Major Metabolic Organs of Wild-Type and Efflux Transporter Knockout FVB Mice.

  2017cites this paper
• Disposition of Flavonoids for Personal Intake

  2017cites this paper
• The Breast Cancer Resistance Protein (BCRP/ABCG2) influences the levels of enterolignans and their metabolites in plasma, milk and mammary gland

  2017cites this paper
• Glucuronidation: driving factors and their impact on glucuronide disposition

  2017influential citation
• High-Throughput and Reliable Isotope Label-free Approach for Profiling 24 Metabolic Enzymes in FVB Mice and Sex Differences

  2017cites this paper
• Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition.

  2016cites this paper
• Cremophor EL-based nanoemulsion enhances transcellular permeation of emodin through glucuronidation reduction in UGT1A1-overexpressing MDCKII cells.

  2016cites this paper
• Challenges and Opportunities with Predicting In Vivo Phase II Metabolism via Glucuronidation From In Vitro Data

  2016cites this paper
• Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport

  2016cites this paper
• Arylsulfatase B Mediates the Sulfonation-Transport Interplay in Human Embryonic Kidney 293 Cells Overexpressing Sulfotransferase 1A3

  2016cites this paper
• Efflux transport of chrysin and apigenin sulfates in HEK293 cells overexpressing SULT1A3: The role of multidrug resistance-associated protein 4 (MRP4/ABCC4).

  2015cites this paper
• Sulfonation of raloxifene in HEK293 cells overexpressing SULT1A3: Involvement of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in excretion of sulfate metabolites.

  2015cites this paper
• Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Controls Efflux Transport of Hesperetin Sulfates in Sulfotransferase 1A3–Overexpressing Human Embryonic Kidney 293 Cells

  2015influential citation
• Decreased Expression of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) Leads to Reduced Glucuronidation of Flavonoids in UGT1A1-Overexpressing HeLa Cells: The Role of Futile Recycling.

  2015cites this paper
• Sugar conjugates of 3-hydroxy-4-pyridinones : synthesis and investigations into their potential for drug delivery to the brain

  2015cites this paper
• Disposition of mianserin and cyclizine in UGT2B10-overexpressing HEK293 cells: Identification of UGT2B10 as a novel N-glucosidation enzyme and BCRP as an N-glucoside transporter

  year unknowncites this paper